|
|
||||||||
1 Laboratoire pour l'Utilisation du Rayonnement Electromagnétique (CNRS, CEA, MER), Université Paris-Sud, F-91898 Orsay Cedex, France
2 Laboratoire de Biochimie des Signaux Régulateurs Cellulaires et Moléculaires, UMR-CNRS 7631, Université Pierre et Marie Curie, F-75006 Paris, France
3 Laboratoire de Biotechnologies et Pharmacologie Génétique Appliquée, UMR-CNRS 8532, Ecole Normale Supérieure de Cachan, F-94235 Cachan, France
4 Merkert Chemistry Center, Department of Chemistry, Boston College, Chestnut Hill, Massachusetts 02467, USA
Reprint requests to: P. Vachette, Laboratoire pour l'Utilisation du Rayonnement Electromagnétique (CNRS, CEA, MER), B|fqtiment 209D, B.P. 34, Université Paris-Sud, F-91898 Orsay Cedex, France; e-mail vachette{at}lure.u-psud.fr; fax +33-1-64-46-41-48.
(RECEIVED November 13, 2001; FINAL REVISION January 23, 2002; ACCEPTED January 29, 2002)
Article and publication are at http://www.proteinscience.org/cgi/doi/10.1110/ps.4500102.
5 Present address: Laboratoire Physico-Chimie Curie, UMR 168, Institut Curie, F-75248 Paris Cedex 05, France. ![]()
6 Present address: Biogen Inc., Cambridge, Massachusetts 02142, USA. ![]()
| Abstract |
|---|
|
|
|---|
Keywords: Aspartate transcarbamoylase; small-angle X-ray scattering; allostery; cooperativity; quaternary structural changes
Abbreviations: ATCase, aspartate transcarbamoylase (carbamoyl phosphate: L-aspartate transferase) from E. coli (EC 2.1.3.2.) [Asp]0.5, the aspartate concentration at half the maximal observed specific activity PALA, N-(phosphonacetyl)-L-aspartate 160's loop, loop region in the catalytic chain corresponding to residues 160-166 240's loop, loop region encompassing residues 230-245 in the catalytic chain SAXS, small-angle X-ray scattering holoenzyme, the entire molecule consisting of six catalytic chains and six regulatory chains c followed by a number, e.g., c1 or c4, refers to a particular catalytic chain
| Introduction |
|---|
|
|
|---|
The holoenzyme (306 kD) is composed of two catalytic trimers (102 kD) and three regulatory dimers (34 kD) assembled with approximate D3 symmetry. Each catalytic chain contains two domains, the aspartate domain and the carbamoyl phosphate domain, the active site being located between the two domains (Monaco et al. 1978; Robey and Schachman 1985; Krause et al. 1987; Wente and Schachman 1987). Two domains are also present in the regulatory chains: the allosteric domain, which contains the nucleotide binding site located some 60 Å away from the nearest active site, and the zinc domain, which is in contact with the catalytic chain. The cooperative and regulatory properties of ATCase have been related to ligand-promoted conformational changes (Gerhart and Schachman, 1968; Monaco et al. 1978; Moody et al. 1979), interpreted for the most part within the framework of the concerted Monod, Wyman, and Changeux (1965) model with two quaternary structures, T and R (Monod et al. 1965). Crystallographic studies (Honzatko et al. 1982; Ke et al. 1984; Krause et al. 1987; Ke et al.1988) revealed that the cooperative transition after binding of various substrate analogs results in an expansion of 10.8 Å along the threefold axis, with a 12° rotation of the catalytic trimers relative to one another around this axis, coupled to a 15° rotation of each of the three regulatory dimers around the twofold axes (Lipscomb 1994). Small-angle X-ray scattering (SAXS) studies showed that the scattering pattern of the holoenzyme, characteristic of the quaternary structure of the enzyme, changes dramatically on substrate binding (Moody et al. 1979; Hervé et al. 1985). Comparison of the experimental SAXS profiles with calculated curves from atomic coordinates showed the existence of large differences between the solution and crystal quaternary structures in the R state (Svergun et al. 1997; Fetler and Vachette 2001). The elongation along the molecular threefold axis is about 2.8 Å larger in solution than in the crystal, accompanied by increased amplitudes of rotation. These large quaternary changes are accompanied by various alterations in the tertiary structure of both the catalytic and regulatory subunits, as observed by X-ray crystallography (Krause et al. 1987; Ke et al. 1988; Jin et al. 1999). More specifically, the cleft between the carbamoyl phosphate and the aspartate domains of the catalytic chains closes and the 240's loop, encompassing residues 230245, at the c1-c4 interface undergoes a major reorientation. Numerous studies with site-specific mutants have pointed out the importance of this loop in the homotropic cooperative and allosteric properties of the enzyme (Middleton and Kantrowitz 1986; Ladjimi et al. 1988; Middleton et al. 1989; Newton and Kantrowitz 1990; Stebbins et al. 1990), and other studies have shown that its position is directly related to substrate binding in the corresponding active site (Fetler et al. 1995). Close to the 240's loop and the active site, another loop region (161166) plays a potential role in the internal architecture of the enzyme and its regulatory properties (Newton et al. 1992). Asp-162 interacts with nitrogen atoms of the peptide backbone of Lys-164 and Tyr-165, two residues that have been shown to stabilize the c1-c4 interface through intertrimer interactions with Glu-239 in the T-state and intratrimer interactions with Glu-239 in the R-state (Fig. 1
) (Kantrowitz and Lipscomb 1988). The side chain of Asp-162 makes another interaction, in both T- and R-states, with Gln-231, a residue involved in the binding of aspartate. To investigate the functional role of Asp-162, a phylogenetically conserved residue that has no direct catalytic role, it was replaced by an alanine residue (Newton et al. 1992). This D162A mutant shows a major reduction in the maximal observed specific activity, a loss of homotropic cooperativity, an absence of inhibition by CTP and, at variance with former results (Newton et al. 1992), a twofold decrease for aspartate affinity and a twofold reduced activation by ATP. In the absence of additional structural data, earlier results were interpreted assuming the mutant enzyme was in the R-functional state. The low activity, atypical of the R-state, was attributed to a repositioning of the side chains in the immediate vicinity of Asp-162, which could destabilize crucial interactions involving neighboring residues Lys-164, Tyr-165, and Gln-231. In the absence of high resolution atomic coordinates for the D162A mutant, SAXS patterns were recorded for this mutant in the presence of different substrates and/or nucleotide effectors to determine whether the postulated R-functional state in this mutant correlates with an R-structure.
|
| Results and Discussion |
|---|
|
|
|---|
|
|
Effect of nucleotide effectors on the quaternary structure
SAXS measurements showed that the nucleotide activator ATP only induces a small increase of the first subsidiary minimum of the scattering profile of the wild-type enzyme, which has recently been shown to be a direct contribution of bound ATP to the scattering intensity with no conformational change of the enzyme (Fetler and Vachette 2001). Crystallographic studies revealed an apparent 0.5 Å separation of the wild-type catalytic trimers along the C3 axis of symmetry (Stevens et al. 1990) at the detection limit of SAXS measurements. In the presence of ATP, a significant intensity increase in the first subsidiary minimum and maximum of the scattering profile of the D162A enzyme can be observed (Fig. 4
), which is at variance with the results obtained with the wild-type enzyme and the various mutants studied so far. Indeed, the scattering curves of the D162A enzyme in the presence of ATP alone or a twofold molar excess of PALA per active site are quite similar (Fig. 5
). This observation must be related to the recent activity measurement data, showing that ATP can activate the mutant enzyme to some extent (Table 1
). Hence, this newly observed structure, although different from the R-structure, must have some improved affinity and/or activity for the substrates. Because the mutant does not show any cooperativity for aspartate as judged from activity measurements, this conformation is likely to remain inaccessible even in the presence of the natural substrates carbamoyl phosphate and aspartate, as observed with carbamoyl phosphate and succinate. This could be determined experimentally but because of the consumption of substrates by the enzyme, it would require time-resolved SAXS measurements in which the enzyme is rapidly mixed with the substrates in the presence of ATP and the transient steady-state conformation is recorded (Tsuruta et al. 1998). However, such experiments require a higher flux than that available with the instrument used here.
|
|
|
To complement these structural observations, ATP activation was measured with the wild-type and the D162A enzyme in the presence or absence of PALA. For the wild-type enzyme, the more than fourfold activation by the nucleotide activator ATP vanishes in the presence of 2 µM PALA (Table 1
). This is interpreted as indicating that PALA binding was sufficient to convert the enzyme to the active R-state, with no further activation left for ATP to perform. Under the same conditions, the mutant enzyme behaves much differently, because a twofold activation by ATP is observed regardless of the presence of PALA. However, the concentration of PALA used, which had to be kept low enough to leave free active sites for substrates to bind and the reaction to occur, was probably insufficient to alter the scattering pattern. Therefore, the apparent inconsistency between structural and activity observations may be attributable to this experimental limitation.
A modeling procedure using rigid body movements has already been used to propose a model for the quaternary structure of the R-state of the enzyme in solution (Svergun et al. 1997) and, more recently, for the conformation of the ternary complex of the enzyme with PALA and Mg-ATP (Fetler and Vachette 2001). The same approach was applied here to the conformation of the mutant enzyme complexed with PALA and ATP. However, no satisfactory model could be obtained by this simple procedure. The failure of our modeling attempt may be caused by intra- and/or interchain rearrangements following the mutation, which would lead to domain movements not accounted for in our scheme based on the wild-type T to R quaternary structure transition. Previous computer simulations of the energy-minimized D162A enzyme in the T- and R-states showed that the side chain of Gln-231 is able to move into the space once occupied by the side chain of Asp-162 (Newton et al. 1992). This reorientation of Gln-231, preventing its interaction with aspartate, could be responsible for the reduced maximal observed specific activity. The discrepancies between the calculated and the experimental scattering patterns of the mutant enzyme in the presence of ATP and PALA indicate that the perturbations induced by the mutation affects other residues in this critical part of the molecule close to the r1-c1, r1-c4, and c1-c4 interfaces, which are reorganized in the quaternary structure transition. From the scattering pattern of the unliganded mutant enzyme, it appears that the mutation does not affect the T conformation. In contrast, it severely affects the quaternary structure transition because PALA has a very limited effect and even the combined action of PALA and ATP cannot convert the enzyme into the wild-type R conformation. This is most likely attributable to modifications to one or several of the above mentioned interfaces. Only a high-resolution study of the ternary complex of the mutant enzyme with PALA and ATP could give some insight into the mechanism underlying the crucial role played by Asp-162 in the stability of the quaternary structure of ATCase and, most importantly, its central involvement in the transition into the R structure shown by our solution studies.
| Materials and methods |
|---|
|
|
|---|
Enzyme preparation and assay
The wild-type and the D162A mutant ATCase were isolated from the E. coli strain EK1104 (F-ara, thi,
pro-lac,
pyrB, pyrF±, and rpsL) containing the plasmids pEK2 (Smith et al. 1986) and pEK141 (Newton et al. 1992), respectively. The holoenzymes were purified to electrophoretic homogeneity essentially as described by Nowlan and Kantrowitz (Nowlan and Kantrowitz 1985), except that an additional isoelectric precipitation step was used.
The ATCase activity was measured at 25°C by a colorimetric method (Prescott and Jones 1969; Pastra-Landis et al. 1981). Colorimetric assays were performed in 50 mM Tris-acetate buffer, pH 8.3. The nucleotide assays were performed at half the [Asp]0.5 value. The analysis of steady-state kinetic data was performed as previously described (Silver et al. 1983). Fitting of the experimental data to theoretical equations was accomplished by nonlinear regression. When substrate inhibition was negligible, data were fit to the Hill equation. When substrate inhibition was significant, data were analyzed using an extension of the Hill equation that included a term for substrate inhibition (Pastra-Landis et al. 1978). The nucleotide saturation curves were fit to a hyperbolic isotherm by nonlinear regression.
Solution X-ray scattering
X-ray scattering curves were recorded on the small-angle scattering instrument D24 using synchrotron radiation at LURE-DCI, Orsay. The instrument, the data acquisition system (Boulin et al. 1986), and the experimental procedures (Fetler et al. 1995) have already been described. The purified enzyme solution was buffered with 50 mM Tris-HCl at pH 8.3 and contained 0.1 mM dithiothreitol, a strong reducing agent. The samples for X-ray scattering experiments were prepared to a final protein concentration of 50 mg.mL-1, except for the smallest angle data recorded at 5 mg.mL-1. The concentration of protein was determined by absorbance measurements at 280 nm using an extinction coefficient of 0.59 cm2.mg-1 (Gerhart and Holoubek 1967).
The intensity scattered by a noninteracting solution of protein is the sum of the intensities of all individual particles. In the case of a mixture of different particles, the resulting intensity is the sum of the contributions of each particle weighted by their fractional concentrations. In the present work, our samples only contain ATCase, which can adopt different quaternary structures (e.g., the T- and R-state) with different associated scattering patterns. If a solution contains a mixture of two quaternary structures, its scattering pattern will therefore be a linear combination of the individual patterns weighted by the respective fractional concentrations.
The modeling procedure using rigid body movements of the subunits has already been presented (Fetler and Vachette 2001).
| Acknowledgments |
|---|
The publication costs of this article were defrayed in part by payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 USC section 1734 solely to indicate this fact.
| References |
|---|
|
|
|---|
Baker, D.P., Fetler, L., Vachette, P., and Kantrowitz, E.R. 1996. The allosteric activator ATP induces a substrate-dependent alteration of the quaternary structure of a mutant aspartate transcarbamoylase impaired in active site closure. Protein Sci. 5: 22762286.[Abstract]
Bethell, M.R., Smith, K.E., White, J.S., and Jones, M.E. 1968. Carbamyl phosphate: An allosteric substrate for aspartate transcarbamylase of Escherichia coli. Proc. Natl. Acad. Sci. 60: 14421444.
Boulin, C., Kempf, R., Koch, M.H.J., and McLaughlin, S.M. 1986. Data appraisal, evaluation and display for synchrotron radiation experiments: Hardware and software. Nucl. Instrum. and Meth. A249: 399407.
Cherfils, J., Sweet, R.M., Middleton, S.A., Kantrowitz, E.R., Tauc, P., and Vachette, P. 1989. Structural consequences of a one atom mutation on aspartate transcarbamylase from E. coli. FEBS Lett. 247: 361366.[CrossRef][Medline]
Cherfils, J., Vachette, P., Tauc, P., and Janin, J. 1987. The pAR5 mutation and the allosteric mechanism of Escherichia coli aspartate carbamoyltransferase. EMBO J. 6: 28432847.[Medline]
Collins, K.D. and Stark, G.R. 1971. Aspartate transcarbamylase: Interaction with the transition state analogue N-(phosphonacetyl)-L-aspartate. J. Biol. Chem. 246: 65996605.
Fetler, L., Tauc, P., Hervé, G., Moody, M.F., and Vachette, P. 1995. X-ray scattering titration of the structure transition of aspartate transcarbamylase with a bisubstrate analogue. Influence of nucleotide effectors. J. Mol. Biol. 251: 243255.[CrossRef][Medline]
Fetler, L., Tauc, P., and Vachette, P. 1997. Carbamyl phosphate modifies the T quaternary structure of aspartate transcarbamylase, thereby facilitating the structural transition associated with cooperativity. J. Appl. Cryst. 30: 781786.
Fetler, L. and Vachette, P. 2001. The allosteric activator Mg-ATP modifies the quaternary structure of the R-state of Escherichia coli aspartate transcarbamylase without altering the T to R equilibrium. J. Mol. Biol. 309: 817832.[CrossRef][Medline]
Fetler, L., Vachette, P., Hervé, G., and Ladjimi, M.M. 1995. Unlike the quaternary structure transition, the tertiary structure change of the 240s loop in allosteric aspartate transcarbamylase requires active site saturation by substrate for completion. Biochemistry 34: 1565415660.[CrossRef][Medline]
Gerhart, J.C. and Holoubek, H. 1967. The purification of aspartate transcarbamylase of Escherichia coli and separation of its protein subunits. J. Biol. Chem. 242: 28862892.
Gerhart, J.C. and Pardee, A.B. 1962. The enzymology of control by feedback inhibition. J. Biol. Chem. 237: 891896.
Gerhart, J.C. and Schachman, H.K. 1968. Allosteric interactions in aspartate trancarbamylase. II. Evidence for different conformational states of the protein in the presence and absence of specific ligands. Biochemistry 7: 538552.[Medline]
Hervé, G. 1989. Aspartate transcarbamylase from Escherichia coli. In Allosteric enzymes (ed. G. Hervé), pp. 6179, CRC Press, Boca Raton, Florida.
Hervé, G., Moody, M.F., Tauc, P., Vachette, P., and Jones, P.T. 1985. Quaternary structure changes in aspartate transcarbamylase studied by X-ray solution scattering. Signal transmission following effector binding. J. Mol. Biol. 185: 189199.[CrossRef][Medline]
Honzatko, R.B., Crawford, J.L., Monaco, H.L., Ladner, J.E., Ewards, B.F.P., Evans, D.R., Warren, S.G., Wiley, D.C., Ladner, R.C., and Lipscomb, W.N. 1982. Crystal and molecular structures of native and CTP-liganded aspartate carbamoyltransferase from Escherichia coli. J. Mol. Biol. 160: 219263.[CrossRef][Medline]
Howlett, G.J. and Schachman, H.K. 1977. Allosteric regulation of aspartate transcarbamoylase. Changes in the sedimentation coefficient promoted by the bisubstrate analogue N-(phosphonacetyl)-L-aspartate. Biochemistry 16: 50775083.[CrossRef][Medline]
Jacobson, G.R. and Stark, G.R. 1973. Aspartate transcarbamylase. A study of possible roles for the sulfhydryl group at the active site. J. Biol. Chem. 248: 80038014.
Jin, L., Stec, B., Lipscomb, W.N., and Kantrowitz, E.R. 1999. Insights into the mechanisms of catalysis and heterotropic regulation of Escherichia coli aspartate transcarbamoylase based on a structure of the enzyme complexed with the bisubstrate analogue N-phosphonacetyl-L-aspartate at 2.1 A. Proteins 37: 729742.[CrossRef][Medline]
Jones, M.E., Spector, L., and Lipmann, F. 1955. Carbamoylphosphate, the carbamyl donor in enzymatic citrulline synthesis. J. Am. Chem. Soc. 77: 819820.[CrossRef]
Kantrowitz, E.R. and Lipscomb, W.N. 1988. Escherichia coli aspartate transcarbamylase: The relation between structure and function. Science 241: 669674.
Kantrowitz, E.R. and Lipscomb, W.N. 1990. Escherichia coli aspartate transcarbamoylase: The molecular basis for a concerted allosteric transition. Trends Biochem. Sci. 15: 5359.[CrossRef][Medline]
Ke, H., Honzatko, R.B., and Lipscomb, W.N. 1984. Structure of unliganded aspartate carbamoyl transferase of Escherichia coli at 2.6 Å resolution. Proc. Natl. Acad. Sci. 81: 40374040.
Ke, H., Lipscomb, W.N., Cho, Y., and Honzatko, R.B. 1988. Complex of N-phosphonacetyl-L-aspartate with aspartate carbamoyltransferase. X-ray refinement, analysis of conformational changes and catalytic and allosteric mechanisms. J. Mol. Biol. 204: 725748.[CrossRef][Medline]
Krause, K.L., Volz, K.W., and Lipscomb, W.N. 1987. 2.5 Å structure of aspartate carbamoyltranferase complexed with the bisubstrate analog N-(phosphonacetyl)-L-aspartate. J. Mol. Biol. 193: 527553.[CrossRef][Medline]
Ladjimi, M.M., Middleton, S.A., Kelleher, K.S., and Kantrowitz, E.R. 1988. Relationship between domain closure and binding, catalysis, and regulation in Escherichia coli aspartate transcarbamylase. Biochemistry 27: 268276.[CrossRef][Medline]
Lipscomb, W.N. 1994. Aspartate transcarbamylase from Escherichia coli: Activity and regulation. Adv. Enzymol. 68: 67152.
Macol, C., Dutta, M., Stec, B., Tsuruta, H., and Kantrowitz, E.R. 1999. The 80s loop of the catalytic chain of Escherichia coli aspartate transcarbamoylase is critical for catalysis and homotropic cooperativity. Protein Sci. 8: 13051313.[Abstract]
Macol, C.P., Tsuruta, H., Stec, B., and Kantrowitz, E.R. 2001. Direct structural evidence for a concerted allosteric transition in Escherichia coli aspartate transcarbamoylase. Nat. Struct. Biol. 8: 423426.[CrossRef][Medline]
Middleton, S.A. and Kantrowitz, E.A. 1986. Importance of the loop at residues 230245 in the allosteric interactions of Escherichia coli aspartate carbamoyltransferase. Proc. Natl. Acad. Sci. 83: 58665870.
Middleton, S.A., Stebbins, J.W., and Kantrowitz, E.R. 1989. A loop involving catalytic chain residues 230245 is essential for the stabilization of both allosteric forms of Escherichia coli aspartate transcarbamylase. Biochemistry 28: 16171626.[CrossRef][Medline]
Monaco, H.L., Crawford, J.L., and Lipscomb, W.N. 1978. Three-dimensional structures of aspartate carbamoyltransferase from Escherichia coli and of its complex with cytidine triphosphate. Proc. Natl. Acad. Sci. 75: 52765280.
Monod, J., Wyman, J., and Changeux, J.P. 1965. On the nature of allosteric transitions. A plausible model. J. Mol. Biol. 12: 88118.[Medline]
Moody, M.F., Vachette, P., and Foote, A.M. 1979. Changes in the X-ray solution scattering of aspartate transcarbamylase following the allosteric transition. J. Mol. Biol. 133: 517532.[CrossRef][Medline]
Newton, C.J. and Kantrowitz, E.R. 1990. Importance of domain closure for homotropic cooperativity in Escherichia coli aspartate transcarbamylase. Biochemistry 29: 14441451.[CrossRef][Medline]
Newton, C.J., Stevens, R.C., and Kantrowitz, E.R. 1992. Importance of a conserved residue, aspartate-162, for the function of Escherichia coli aspartate transcarbamoylase. Biochemistry 31: 30263032.[CrossRef][Medline]
Nowlan, S.F. and Kantrowitz, E.R. 1985. Superproduction and rapid purification of Escherichia coli aspartate transcarbamylase and its catalytic subunit under extreme derepression of the pyrimidine pathway. J. Biol. Chem. 260: 1471214716.
Pastra-Landis, S.C., Evans, D.R., and Lipscomb, W.N. 1978. The effect of pH on the cooperative behavior of aspartate transcarbamoylase from E. coli. J. Biol. Chem. 253: 46244630.
Pastra-Landis, S.C., Foote, J., and Kantrowitz, E.R. 1981. An improved colorimetric assay for aspartate and ornithine transcarbamylases. Anal. Biochem. 118: 358363.[CrossRef][Medline]
Prescott, L.M. and Jones, M.E. 1969. Modified methods for the determination of carbamyl aspartate. Anal. Biochem. 32: 408419.[CrossRef][Medline]
Reichard, P. and Hanshoff, G. 1956. Aspartate carbamyl transferase from Escherichia coli. Acta Chem. Scand. 10: 548566.
Robey, E.A. and Schachman, H.K. 1985. Regeneration of active enzyme by formation of hybrids from inactive derivatives: Implications for active sites shared between polypeptide chains of aspartate transcarbamylase. Proc. Natl. Acad. Sci. 82: 361365.
Silver, R.S., Daigneault, J.P., Teague, P.D., and Kantrowitz, E.R. 1983. Analysis of two purified mutants of Escherichia coli aspartate transcarbamylase with single amino acid substitutions. J. Mol. Biol. 168: 729745.[CrossRef][Medline]
Smith, K.A., Nowlan, S.F., Middleton, S.A., O'Donovan, C., and Kantrowitz, E.R. 1986. Involvement of Tryptophan 209 in the allosteric interactions of Escherichia coli aspartate transcarbamylase using single amino acid substitution mutants. J. Mol. Biol. 189: 227238.[CrossRef][Medline]
Stebbins, J.W., Zhang, Y., and Kantrowitz, E.R. 1990. Importance of residues Arg-167 and Gln-231 in both the allosteric and catalytic mechanisms of Escherichia coli aspartate transcarbamoylase. Biochemistry 29: 38213827.[CrossRef][Medline]
Stevens, R.C., Gouaux, J.E., and Lipscomb, W.N. 1990. Structural consequences of effector binding to the T state of aspartate carbamoyltransferase : Crystal structures of the unligated and ATP- and CTP-complexed enzymes at 2.6-Å resolution. Biochemistry 29: 76917701.[CrossRef][Medline]
Svergun, D.I., Barberato, C., Koch, M.H., Fetler, L., and Vachette, P. 1997. Large differences are observed between the crystal and solution quaternary structures of allosteric aspartate transcarbamylase in the R state. Proteins 27: 110117.[CrossRef][Medline]
Tauc, P., Keiser, R.T., Kantrowitz, E.R., and Vachette, P. 1994. Glu-50 in the catalytic chain of Escherichia coli aspartate transcarbamoylase plays a crucial role in the stability of the R quaternary structure. Protein Sci. 3: 19982004.[Abstract]
Tauc, P., Vachette, P., Middleton, S.A., and Kantrowitz, E.R. 1990. Structural consequences of the replacement of Glu239 by Gln in the catalytic chain of Escherichia coli aspartate transcarbamylase. J. Mol. Biol. 214: 327335.[CrossRef][Medline]
Tsuruta, H., Vachette, P., and Kantrowitz, E.R. 1998. Direct observation of an altered quaternary-structure transition in a mutant aspartate transcarbamoylase. Proteins 31: 383390.[CrossRef][Medline]
Wente, S.R. and Schachman, H.K. 1987. Shared active sites in oligomeric enzymes model studies with defective mutants of aspartate transcarbamoylase produced by site-directed mutagenesis. Proc. Natl. Acad. Sci. 84: 3135.
Wild, J.R., Loughrey-Chen, S.J., and Corder, T.S. 1989. In the presence of CTP, UTP becomes an allosteric inhibitor of aspartate transcarbamoylase. Proc. Natl. Acad. Sci. 86: 4650.
![]()
CiteULike
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |